Article
Thwarting resistance: MgrA inhibition with methylophiopogonanone a unveils a new battlefront against S. aureus
27 Feb 2024
Abstract excerpt
Limitations in the clinical treatment of Staphylococcus aureus (S. aureus) infections have arisen due to the advent of antibiotic-resistant strains. Given the immense potential of therapeutic strategies targeting bacterial virulence, the role of MgrA as a pivotal virulence determinant in S. aureus-orchestrating resistance, adherence, and hundreds of virulence targets-becomes indispensable. In this investigation,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
